Integrated mobile health program for women with gynecological cancer
Developing and Testing an Integrated mHealth Learning Program for Gynecological Cancer
This study is testing a new mobile health program designed to help women with gynecological cancer in Taiwan manage their symptoms and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | Female |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Taoyuan, Guishan Dist.) |
| Trial ID | NCT06552494 on ClinicalTrials.gov |
What this trial studies
This project aims to develop and test an integrated mobile health learning program specifically designed for women with gynecological cancer in Taiwan. The program will be co-created with input from patients and experts to ensure it meets the educational needs of this population. A randomized controlled trial will be conducted with 120 participants, where women will be assigned to either the intervention group receiving the mobile health program or a control group receiving standard care. Data will be collected at multiple time points to assess the program's effectiveness in improving symptom management and quality of life.
Who should consider this trial
Good fit: Ideal candidates are women aged 20 to 70 diagnosed with ovarian cancer at Stage 3 or below, who can use an internet-enabled mobile device.
Not a fit: Patients with a history of other malignant tumors or those with intellectual disabilities or mental disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the quality of life and symptom management for women with gynecological cancer.
How similar studies have performed: Other studies have shown promise in using mobile health interventions for cancer care, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women definitively or suspected to be diagnosed with ovarian cancer, with the cancer staged at Stage 3 or below. 2. Women receiving surgery, chemotherapy, or immunotherapy at the recruiting hospital. 3.20 to 70 years old. 4.Possesses and is able to use an internet-enabled mobile device (such as a smartphone or tablet). 5.Able to clearly communicate and read/write in Mandarin or Taiwanese. 6.Agrees to participate in the study and signs the informed consent form. Exclusion Criteria: 1. History of other malignant tumors. 2. Intellectual disability or mental disorders.
Where this trial is running
Taoyuan, Guishan Dist.
- Cheng Gung Memorial Hospital — Taoyuan, Guishan Dist., Taiwan (Recruiting)
Study contacts
- Principal investigator: Jian Tao LEE, Professor — Chang Gung University
- Study coordinator: Jian Tao LEE, Professor
- Email: jtlee@gap.cgu.edu.tw
- Phone: 886-03-2118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.